Teladoc Health Inc (NYSE: TDOC)’s stock price has plunge by -6.22relation to previous closing price of 6.83. Nevertheless, the company has seen a -11.66% plunge in its stock price over the last five trading sessions. seekingalpha.com reported 2025-04-16 that Teladoc Health, Inc.’s stock has declined significantly, from a high of $14 per share in February to $7 per share, with ongoing financial struggles and underperformance in key segments. The company reported a net loss of $1 billion in 2024, with declining revenues in its BetterHelp segment and minimal growth in Integrated Care. Despite efforts to cut costs and new initiatives like the Catapult Health acquisition and a partnership with Eli Lilly, Teladoc’s value proposition remains unclear.
Is It Worth Investing in Teladoc Health Inc (NYSE: TDOC) Right Now?
Company’s 36-month beta value is 1.82.Analysts have differing opinions on the stock, with 3 analysts rating it as a “buy,” 2 as “overweight,” 19 as “hold,” and 0 as “sell.”
The public float for TDOC is 173.46M, and currently, short sellers hold a 12.52% ratio of that floaft. The average trading volume of TDOC on April 21, 2025 was 7.86M shares.
TDOC’s Market Performance
TDOC stock saw a decrease of -11.66% in the past week, with a monthly decline of -21.60% and a quarterly a decrease of -29.54%. The volatility ratio for the week is 4.13%, and the volatility levels for the last 30 days are 6.28% for Teladoc Health Inc (TDOC). The simple moving average for the past 20 days is -15.92% for TDOC’s stock, with a -30.29% simple moving average for the past 200 days.
Analysts’ Opinion of TDOC
Many brokerage firms have already submitted their reports for TDOC stocks, with Goldman repeating the rating for TDOC by listing it as a “Buy.” The predicted price for TDOC in the upcoming period, according to Goldman is $14 based on the research report published on November 15, 2024 of the previous year 2024.
Jefferies, on the other hand, stated in their research note that they expect to see TDOC reach a price target of $10, previously predicting the price at $8. The rating they have provided for TDOC stocks is “Hold” according to the report published on September 17th, 2024.
Cantor Fitzgerald gave a rating of “Overweight” to TDOC, setting the target price at $22 in the report published on February 29th of the previous year.
TDOC Trading at -31.68% from the 50-Day Moving Average
After a stumble in the market that brought TDOC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -57.89% of loss for the given period.
Volatility was left at 6.28%, however, over the last 30 days, the volatility rate increased by 4.13%, as shares sank -23.60% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -46.32% lower at present.
During the last 5 trading sessions, TDOC fell by -11.38%, which changed the moving average for the period of 200-days by -31.65% in comparison to the 20-day moving average, which settled at $7.62. In addition, Teladoc Health Inc saw -29.54% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at TDOC starting from Murthy Mala, who sale 7,494 shares at the price of $6.81 back on Apr 07 ’25. After this action, Murthy Mala now owns 121,467 shares of Teladoc Health Inc, valued at $51,012 using the latest closing price.
Murthy Mala, the Officer of Teladoc Health Inc, proposed sale 7,494 shares at $6.81 during a trade that took place back on Apr 07 ’25, which means that Murthy Mala is holding shares at $51,012 based on the most recent closing price.
Stock Fundamentals for TDOC
Current profitability levels for the company are sitting at:
- -0.09 for the present operating margin
- 0.63 for the gross margin
The net margin for Teladoc Health Inc stands at -0.39. The total capital return value is set at -0.09. Equity return is now at value -52.46, with -23.65 for asset returns.
Based on Teladoc Health Inc (TDOC), the company’s capital structure generated 0.52 points at debt to capital in total, while cash flow to debt ratio is standing at 0.19. The debt to equity ratio resting at 1.06. The interest coverage ratio of the stock is -9.2.
Currently, EBITDA for the company is -587.01 million with net debt to EBITDA at -0.49. When we switch over and look at the enterprise to sales, we see a ratio of 0.55. The receivables turnover for the company is 11.47for trailing twelve months and the total asset turnover is 0.73. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.73.
Conclusion
In a nutshell, Teladoc Health Inc (TDOC) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
